The money map

The Academy's deepest specialist module, and the one with the shortest shelf life. Module 07 gave you the map: who the NHS is, who sits round the table, which gates exist. This module is the terrain — how the money actually moves, what each person in the room can and cannot do for you, how a tender is really scored, what a pilot contract must say, and what fourteen months of an NHS deal looks like week by week. Everything here is written to two layers: the durable structure, which changes slowly and is worth learning cold, and the current position, which changes annually and is date-stamped. Facts in this module were checked in August 2026. Where you see a "check the current position" flag, treat the detail as perishable and verify it before you put it in a bid, an email or an interview answer.

What you'll learn

• How NHS money actually flows — Parliament to DHSC to commissioner to provider — and why "who pays for this?" is usually the hardest question in the deal, not "does anyone want it?".
• The full stakeholder cast: fourteen roles, what each one is measured on, what each can authorise, how to earn their time, and the political fault lines running between them.
• The routes that genuinely get a supplier inside a trust — clinical champions, innovation bodies, national programmes, market engagement — and an honest account of what cold outreach does and doesn't achieve.
• The compliance gauntlet run in the right order, with a clear split between what you need before the first meeting and what you need before contract.
• How a framework call-off and a competitive tender actually run, how evaluators score, how to write for them, and the errors that get bids binned unread.
• Pilot design that converts: the contract terms, the success criteria, the sign-off route and the pricing that stops a pilot eating the real deal.
• The evidence ladder in detail — service evaluation versus research, budget impact versus cost-effectiveness, and the current NICE routes — plus how a small vendor builds evidence on a small budget.
• A realistic fourteen-month deal anatomy: the artefacts, meetings and blockers at every stage.

1. The money map

Most losing NHS deals are not lost on product. They are lost because nobody identified a budget that could legally and practically pay for the thing. A seller who can trace a pound from Parliament to the purchase order does work most competitors never attempt.

The chain, top to bottom

Parliament and the Treasury set the Department of Health and Social Care's spending limits at a Spending Review. Two separate limits matter and they are not interchangeable: RDEL (resource departmental expenditure limit) is day-to-day money — salaries, licences, subscriptions — and CDEL (capital departmental expenditure limit) is investment in assets. You cannot fund revenue costs from capital, and moving between them requires Treasury permission — a distinction that decides more NHS software deals than any feature comparison.

DHSC then allocates, historically passing the bulk of the NHS budget to NHS England through an annual mandate. That machinery is being dismantled: abolition was announced in March 2025, a Health Bill was introduced on 13 May 2026 transferring functions, staff and liabilities to the Secretary of State, ICBs and other bodies, and completion is targeted around April 2027 (check the current position — the Bill was in committee in mid-2026). The letterhead on national guidance is changing; the function is not.

ICBs — Integrated Care Boards — receive allocations and commission services for their population on a weighted capitation basis estimating relative need. The allocation arrives in named envelopes — core services, delegated specialised commissioning, primary care medical services, a running cost allowance — which are not freely interchangeable either. From April 2025 all ICBs took delegated commissioning responsibility for a defined list of specialised services, though accountability stayed with the national body. Two changes matter now: ICBs are consolidating (the first merger phase on 1 April 2026 replaced twelve with six, with more decided for April 2027, so the count is falling from the original 42 — check the current map), and NHS England moved to a medium-term planning framework covering 2026/27 to 2028/29 with multi-year allocations, which makes a line in a three-year plan far more defensible internally than one in a single-year plan.

Providers — trusts and foundation trusts, on the order of two hundred in England (check the current count; mergers are frequent) — are paid under the NHS Payment Scheme, whose 2026/27 version took effect on 1 April 2026. It runs almost all provider activity through aligned payment and incentive (API): a large fixed element agreed between commissioner and provider, plus a variable element paid at national unit prices, with almost all elective activity in the variable part.

Why "who pays" is the hardest question

Follow that payment model through and you find the four traps that kill NHS deals.

One: provider income is largely fixed. Doing the same work with fewer staff hours does not increase a trust's income. It creates capacity — but finance's question is whether the saving is cash-releasing (a post genuinely removed, a contract cancelled, agency spend stopped) or non-cash-releasing (staff get time back and spend it on other work). The latter will not fund a contract alone. Know which you are claiming, and say so before finance says it for you.

Two: benefit and cost land in different organisations. A primary care product that avoids hospital admissions saves money in a trust's budget and costs money elsewhere. This benefit/cost split is why deals with excellent business cases stall for a year. The answer is finding the organisation that holds both sides — usually the ICB — or getting beneficiaries to co-fund.

Three: capital versus revenue. SaaS is revenue; a one-off implementation, hardware or a large build can be capital. Trusts often have capital available and revenue squeezed, or the reverse. Ask directly: "would this sit in your capital programme or your revenue budget, and which is easier this year?"

Four: the efficiency requirement. Provider plans carry an annual efficiency target and a cost improvement programme (CIP) to deliver it. A product contributing to a named CIP line has a sponsor with a target to hit; one that does not competes for discretionary spend that barely exists.

The national pots

Alongside local budgets there are national programmes — smaller than people imagine and highly directive about what they will fund:

• Technology funding for providers currently flows mainly through the Frontline Productivity Programme in NHS England's capital guidance for 2026/27 to 2029/30: regional capital and revenue envelopes calculated from ICB weighted-per-capita data and provider digital maturity scores, targeted at EPR optimisation, cyber security, technology infrastructure and digital medicines. It funds transformation — legacy IT replacement is expected to come from operational capital (check current position; capital guidance is reissued annually).
• The MedTech Funding Mandate (April 2021) obliges commissioners and providers to fund selected NICE-recommended, cost-saving technologies; it remains live but no new products were added for 2026/27 pending review. SBRI Healthcare gives staged development funding against defined NHS challenges — one of very few routes where the NHS pays a small company before it has a customer.
• Transformation and programme funds appear and vanish with policy cycles. The 10 Year Health Plan (July 2025) organised national ambition around three shifts — hospital to community, analogue to digital, sickness to prevention — and money follows that language for as long as the plan does.

How to find out which pot a specific purchase would come from

This is a research task, not a discovery question, and almost entirely doable from a laptop. Read the trust's monthly board papers (finance report, CIP position, capital programme, digital strategy update, risk register — if your product addresses a register risk, you have your business case's first paragraph); the ICB's board papers and joint forward plan, which name the programmes with money attached and the directors accountable; the annual report and accounts for capital and agency spend; Find a Tender and Contracts Finder for what this buyer and its neighbours bought in your category, at what value and on which framework; and pipeline notices for larger authorities' forward view.

Then ask, in the meeting: "If this went ahead, whose budget would it come from, is that capital or revenue, and is it in this year's plan or next year's?" Three sentences that separate you from every competitor who opened with a demo.

Voice from the field

"Over the past 15 years, many sectors of the economy have been radically reshaped by digital technologies. Yet the NHS is in the foothills of digital transformation." … "The NHS has been starved of capital and the capital budget was repeatedly raided to plug holes in day-to-day spending."
— Lord Darzi, Independent Investigation of the NHS in England, summary letter to the Secretary of State (GOV.UK, September 2024)